Citation Impact
Citing Papers
Effect of Low-Level Laser Irradiation on Bisphosphonate-Induced Osteonecrosis of the Jaws: Preliminary Results of a Prospective Study
2009
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction
2013
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.
1998
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer
2018
Engineering precision nanoparticles for drug delivery
2020 Standout
Catalytic Asymmetric Three‐Component Synthesis of Homoallylic Amines
2013 StandoutNobel
Bisphosphonate-related osteonecrosis of the jaws – A review
2012
Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment
1999
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
2017
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
2005
Utility of Hyperbaric Oxygen in Treatment of Bisphosphonate-Related Osteonecrosis of the Jaws
2009
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
1995 Standout
Titrimetric determination of Cremophor® EL in aqueous solutions and biofluids
1999
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
2014
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Cremophor EL
2001 Standout
Paclitaxel (Taxol)
1995 Standout
Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
2011
Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up
2009
Protein corona change the drug release profile of nanocarriers: The “overlooked” factor at the nanobio interface
2014
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Tooth extraction in patients on zoledronic acid therapy
2012
Paclitaxel in cancer therapy
2002
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
2008
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study
2010
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
The microenvironment of the tumour–host interface
2001 StandoutNature
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
1998
Paclitaxel-induced neuropathy
1995
Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.
1995
Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)
2001
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials
2013
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
2017
Role of Formulation Vehicles in Taxane Pharmacology
2001
Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients
2000
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis
2011
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
1997
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
2011
Potential pathophysiological mechanisms in osteonecrosis of the jaw
2011
Quantitation of Cremophor EL in Human Plasma Samples Using a Colorimetric Dye-Binding Microassay
1998
Tooth Extractions in Intravenous Bisphosphonate-Treated Patients: A Refined Protocol
2013
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter
2001
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers
2010
Photodynamic therapy in dermatology
2000
Cervical cancer
2019 Standout
Kaposi's Sarcoma
2000 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Photodynamic Therapy
1999
Cancer of the Ovary
2004 Standout
Albumin-bound paclitaxel: a next-generation taxane
2006
Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833
2001
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis
2012
Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice.
1999
Disposition of [G-3H]paclitaxel and Cremophor EL in a Patient with Severely Impaired Renal Function
1999
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.
2001
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
1998
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
2001
Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem.
2011
Nanoparticles in Photodynamic Therapy
2015 Standout
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
1998
Measurement of Fraction Unbound Paclitaxel in Human Plasma
2000
Pharmacological Effects of Formulation Vehicles
2003
Biochemical Properties and Crystal Structure of a β-Phenylalanine Aminotransferase from Variovorax paradoxus
2012 StandoutNobel
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
1997
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial
2000
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Structural Investigations into the Stereochemistry and Activity of a Phenylalanine-2,3-aminomutase from Taxus chinensis
2014 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
1997
Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
1996
Emerging Targets in Photopharmacology
2016 StandoutNobel
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.
2001
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
2015
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of Manon Huizing being referenced
Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
1999
Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography
1996
RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?
2011
Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer.
1997
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.
1993
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients
2000
Taxanes: A New Class of Antitumor Agents
1995
Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome
2008
Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study
2016
Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces
1995
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
2013
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
2006
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
1997
Osteonecrosis of the jaw related to the use of bisphosphonates
2007
High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine
1995
Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.
2014
Isolation, purification and biological activity of major docetaxel metabolites from human feces.
1996
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
2016
Abstract P6-11-01: Significant Efficacy in a Phase 2 Study of NKTR-102, a Novel Polymer Conjugate of Irinotecan, in Patients with Pre-Treated Metastatic Breast Cancer (MBC)
2010
Hypersensitivity Reactions to the Taxanes Paclitaxel and Docetaxel
1997
Photodynamic Therapy in AIDS-Related Cutaneous Kaposi??s Sarcoma
1995
Open label phase I/II study of Wilms' tumor gene 1 (WT1) mRNA-transfected autologous dendritic cell vaccination in patients with solid tumors.
2012